Target intelligence / Profile preview

S-layer protein A (SlpA) (SlpA)

Target
SlpA
Molecular classification
Cell wall protein, Surface layer protein, Structural protein, Adhesin
01

Overview

S-layer protein A (SlpA) is the primary structural component of the complex surface layer that coats *Clostridioides difficile*, forming an unusually intricate paracrystalline array composed of high- and low-molecular-weight fragments derived from proteolytic cleavage of the SlpA precursor. This surface-exposed protein functions as a multifunctional adhesin and virulence factor, mediating host cell attachment, biofilm formation, immune modulation, and protection from environmental stresses and host defenses. SlpA also serves as the primary receptor for *C. difficile* bacteriophages, making it critical for phage susceptibility. The protein exhibits significant sequence variability between strains, with 13 identified S-layer cassette types that facilitate immune system evasion while maintaining essential structural functions. Although SlpA deletion does not render *C. difficile* non-pathogenic, it substantially reduces virulence through decreased toxin production and impaired host cell adhesion, while paradoxically increasing biofilm formation. The rapid in vivo selection for S-layer-restored variants following infection demonstrates SlpA's essential contribution to disease severity and represents both a promising therapeutic target and a potential challenge due to strong selective pressure favoring its restoration.

Other names
Surface layer protein AHigh-molecular-weight S-layer protein (HMW SLP or HMW SLP)Low-molecular-weight S-layer protein (LMW SLP)P47 (HMW SLP, historical designation)P36 (LMW SLP, historical designation)Cell wall protein (Cwp)
02

Mechanism of action

Potential therapeutic mechanisms targeting SlpA include: Inhibiting SlpA-mediated host cell adhesion; Blocking bacteriophage receptor function to enhance phage therapy; Disrupting S-layer assembly and stability; Enhancing bacterial susceptibility to antimicrobial peptides and bacteriolytic enzymes.

03

Biological functions

Cell surface adhesion and host-cell interactionMolecular sieving and ion trappingProtection from environmental stresses (pH variations, osmotic and mechanical stresses)Protection from antimicrobial peptides and bacteriolytic enzymesBacteriophage receptor/attachment siteBiofilm formationImmune system evasion and immunomodulationCell morphology and structural integrity
04

Disease associations

Clostridioides difficile infection (CDI)Infection/infectious disease
05

Safety considerations

Paradoxical biofilm enhancement: SlpA deletion leads to increased biofilm formation, which could complicate therapeutic strategies if SlpA is targeted directly without addressing compensatory mechanisms.Incomplete understanding of compensatory mechanisms: The roles of SlpA in biofilm formation remain incompletely understood; contradictory results between strains suggest context-dependent effects.Essential in vivo function: The rapid in vivo selection for S-layer-restored variants demonstrates that SlpA function provides significant survival advantages, suggesting that targeting it may face substantial selective pressure.
06

Interacting drugs

Vancomycin
07

Biomarkers

S-layer cassette type (SLCT) variants

Beyond the preview

Go deeper on S-layer protein A (SlpA) (SlpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-layer protein A (SlpA) (SlpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call